EurekAlert! In the Spotlight - Alzheimer's Awareness Month

Welcome to In the Spotlight, where each month we shine a light on something exciting, timely, or simply fascinating from the world of science.

In honor of Alzheimer's Awareness Month, we’re exploring the science and stories surrounding Alzheimer’s disease.

Latest News Releases

Updates every hour. Last Updated: 22-Jun-2026 03:16 ET (22-Jun-2026 07:16 GMT/UTC)

For dementia patients, easy access to experts may help the most

University of California - San Francisco
Peer-Reviewed Publication

A Medicare-covered program that offers support and medical advice for caregivers of patients with dementia may bring more benefit than a costly Alzheimer’s medication, new research finds.

Journal: Alzheimer s & Dementia Behavior & Socioeconomics of Aging
Funder: Alzheimer's Association

Scientists uncover the molecular marvel behind spider silk’s super powers

King's College London
Peer-Reviewed Publication

Scientists have identified the molecular interactions that give spider silk its exceptional strength and flexibility, opening the door to new bio-inspired materials for aircraft, protective clothing and medical applications, and even advancing our understanding of neurological conditions such as Alzheimer’s disease.

Journal: Proceedings of the National Academy of Sciences

Common bacteria discovered in the eye linked to cognitive decline

Cedars-Sinai Medical Center
Peer-Reviewed Publication

A Cedars-Sinai study finds a common bacterium in the eye linked to Alzheimer’s severity, pointing to new approaches to detect and treat the disease.

Journal: Nature Communications

Battling the other 'Alzheimer's protein': Studies ID a novel way to stop toxic tau

University of Colorado at Boulder
Peer-Reviewed Publication

More than two dozen neurodegenerative diseases, including Alzheimer's disease and Chronic Traumatic Encephalopathy (CTE), are driven by toxic proteins called tau aggregates. New resarch illuminates what fuels them and proposes a 'neuronal vaccine' to prevent them.

Journal: Proceedings of the National Academy of Sciences
Funder: Howard Hughes Medical Institute

Improving cognitive impairments in Alzheimer's- the BDNF gene therapy way

Compuscript Ltd
Peer-Reviewed Publication

Alzheimer’s disease (AD) is characterized by the progressive loss of synapses and neurons, leading to devastating cognitive decline. Brain-derived neurotrophic factor (BDNF) protects neurons from apoptosis and helps maintain normal synaptic structures, highlighting it as a potential therapeutic target in Alzheimer's disease. While gene therapy holds promise, in vivo BDNF delivery needs further optimization, and the therapeutic efficacy of BDNF in AD animal models requires further investigation.

Journal: Genes & Diseases
Funder: National Key Research and Development Program of China, National Natural Science Foundation of China

Engineering brain organoids to push new boundaries in Alzheimer’s research

Indiana University

Indiana University researchers are advancing the fight against Alzheimer’s disease using brain organoids, cutting-edge clusters of cells that mimic the structures of the human brain.

44
45
46
47
48